首页> 外国专利> Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof

Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof

机译:包含志贺毒素A亚基效应子区域及其富集组合物的多价CD20结合分子

摘要

The present invention provides multivalent CD20-binding molecules, and compositions thereof, such as enriched compositions comprising large proportions of multivalent CD20-binding molecule relative to monovalent CD20-binding molecule. Certain multivalent CD20-binding molecules of the present invention comprise 1) two or more CD20 binding regions and 2) one or more Shiga toxin effector polypeptide regions derived from an A Subunit of a member of the Shiga toxin family. Certain multivalent CD20-binding molecules of the present invention, and compositions thereof, have uses for selective killing specific cell types and as therapeutics for the treatment of a variety of diseases, including cancers, tumors, and immune disorders. Certain multivalent CD20-binding molecules of the present invention, and compositions thereof, have uses for delivering agents into CD20-expressing cells, including for the intracellular labeling of CD20-expressing cells, collecting diagnostic information, and monitoring the treatment of variety diseases, such as cancers, tumors, and immune disorders which involve CD20-expressing cells.
机译:本发明提供了多价CD20结合分子及其组合物,例如相对于单价CD20结合分子包含高比例的多价CD20结合分子的富集组合物。本发明的某些多价CD20结合分子包含1)两个或多个CD20结合区和2)一个或多个衍生自志贺毒素家族成员的A亚基的志贺毒素效应子多肽区。本发明的某些多价CD20结合分子及其组合物具有用于选择性杀死特定细胞类型的用途,以及用作治疗包括癌症,肿瘤和免疫疾病在内的多种疾病的治疗剂。本发明的某些多价CD20结合分子及其组合物具有用于将试剂递送到表达CD20的细胞中的用途,包括用于表达CD20的细胞的细胞内标记,收集诊断信息以及监测多种疾病的治疗,例如例如涉及CD20表达细胞的癌症,肿瘤和免疫疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号